Global Medical REIT Inc. (GMRE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Global Medical REIT Inc.

    NYSE: GMRE · Real-Time Price · USD
    32.77
    -0.02 (-0.06%)
    At close: Oct 03, 2025, 3:59 PM
    33.38
    1.86%
    After-hours: Oct 03, 2025, 07:13 PM EDT

    Global Medical REIT Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 138.41M 140.93M 137.28M 115.94M
    Cost of Revenue
    		 29.25M 28.08M 25.19M 15.49M
    Gross Profit
    		 109.16M 112.85M 112.09M 100.45M
    Operating Income
    		 32.68M 37.86M 38.83M 37.12M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 6.69M 21.73M 20M 18.34M
    Net Income
    		 6.63M 20.61M -5.23M -2.07M
    Selling & General & Admin
    		 21.12M 16.85M 16.55M 16.45M
    Research & Development
    		 n/a n/a 0.15 0.17
    Other Expenses
    		 55.36M 58.13M 56.72M 46.88M
    Operating Expenses
    		 76.48M 16.9M 73.27M 63.33M
    Interest Expense
    		 28.69M 30.89M 25.23M 19.7M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 105.73M 103.07M 98.46M 78.82M
    Income Tax Expense
    		 n/a n/a 25.23M 20.42M
    Shares Outstanding (Basic)
    		 2.64M 2.62M 2.62M 2.43M
    Shares Outstanding (Diluted)
    		 2.64M 2.62M 2.62M 2.43M
    EPS (Basic)
    		 0.31 5.75 -2 -0.85
    EPS (Diluted)
    		 0.31 5.75 -2 -0.85
    EBITDA
    		 91.47M 111.64M 96.49M 84M
    EBIT
    		 35.38M 52.63M 45.23M 38.04M
    Depreciation & Amortization
    		 56.08M 59.01M 98.81M 78.97M

    Add to Watchlist